title: HBV infection in hemodialysis patients: monitoring and prevention.
abstract: From 1986 to 91, 174 dialysis patients were studied. The prevalence of previous HBV infection and of chronic carriers was 33.3 and 4.6%, respectively. Immunization rate after vaccination (3 doses) was 63%. In 1991, we proposed a vaccination with 4 doses and recommend a 6-monthly anti-HBs evaluation to assess the timing of any booster dose needed.
authors.affiliation: Divisione di Nefrologia e Dialisi, Ospedale Regionale, Torrette, Ancona, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Carletti
authors.forename: L
authors.initials: L
authors.lastname: Bibiano
authors.forename: R
authors.initials: R
authors.lastname: Boggi
authors.forename: E
authors.initials: E
authors.lastname: Bordoni
authors.forename: A M
authors.initials: AM
authors.lastname: Ricciatti
authors.forename: S
authors.initials: S
authors.lastname: Della Bella
authors.forename: P
authors.initials: P
authors.lastname: Pauri
authors.forename: G
authors.initials: G
authors.lastname: Salvoni
authors.forename: V A
authors.initials: VA
authors.lastname: Mioli
mesh_terms: D000368:Aged; D002353:Carrier State / Q000517:prevention & control; D003428:Cross Infection / Q000517:prevention & control / Q000635:transmission; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control / Q000635:transmission*; D006510:Hepatitis B Antibodies / Q000097:blood; D017325:Hepatitis B Vaccines; D006515:Hepatitis B virus / Q000276:immunology; D006521:Hepatitis, Chronic / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D014761:Viral Hepatitis Vaccines / Q000627:therapeutic use
chemical_list: D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines